<DOC>
	<DOCNO>NCT02408471</DOCNO>
	<brief_summary>This study non-randomized , consecutive enrollment , one-year post-approval study patient treat Ascension® MCP .</brief_summary>
	<brief_title>Ascension® Post- Approval Study ; PyroCarbon Metacarpophalangeal Total Joint Prosthesis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Lupus Erythematosus , Systemic</mesh_term>
	<criteria>Indications consistent FDA approve Indications For Use : Index , long , ring , small finger metacarpophalangeal ( MCP ) joint exhibit symptom pain , limited motion , inadequate bony alignment ( i.e. , subluxation/dislocation ) secondary articular destruction degenerative disease relate rheumatoid arthritis , systemic lupus erythematosus , osteoarthritis , posttraumatic arthritis soft tissue reconstruction provide adequate stabilization Willing participate study Signed Informed Consent Form The mean ability return require study visit Are transient Patients follow contraindication exclude study : Inadequate bone stock implantation site Active infection MCP joint Nonfunctioning irreparable MCP musculotendinous system Physical interference prosthesis implantation use Procedures require modification prosthesis Skin , bone , circulatory and/or neurological deficiency implantation site</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Arthritis</keyword>
	<keyword>Rheumatoid Arthritis</keyword>
	<keyword>Systemic Lupus Erythematosus</keyword>
	<keyword>Osteoarthritis</keyword>
	<keyword>Autoimmune Diseases</keyword>
	<keyword>Connective Tissue Diseases</keyword>
	<keyword>Immune System Diseases</keyword>
	<keyword>Joint Diseases</keyword>
	<keyword>Musculoskeletal Diseases</keyword>
	<keyword>Rheumatic Diseases</keyword>
</DOC>